Table 5

Cardiac biomarker characteristics

Cardiac biomarkersPlacebo (n=11)Drug (n=11)p Value
Troponin T (ng/mL)
Immediate pre-PCI0.03 (0.01, 0.13)0.04 (0.01, 0.28)0.44
8 hours0.07 (0.01, 0.15)0.045 (0.03, 0.16)0.67
16 hours0.14 (0.01, 0.18)0.06 (0.02, 0.45)0.84
% Change from immediate pre-PCI to 8 hours35 (0, 300)25 (−6, 68)0.34
% Change from immediate pre-PCI to 16 hours96 (0, 220)33 (0, 73)0.18
% Change from 8 to 16 hours0 (−7, 45)0 (−4, 3)0.47
CK-MB (ng/mL)
Immediate pre-PCI2.8 (2, 3.9)5.5 (2.9, 10.5)0.11
8 hours3.8 (2.8, 9.1)4.8 (2.7, 7.7)0.91
16 hours11 (3.03, 16.18)4.4 (2.8, 8.7)0.23
% Change from immediate pre-PCI to 8 hours26 (−15, 134)−17 (−26, −10)0.020*
% Change from immediate pre-PCI to 16 hours107 (2, 446)−17 (−38, 14)0.007*
% Change from 8 to 16 hours27 (3, 82)−3 (−18, 14)0.11
  • *p<0.05.

  • Data are expressed as median (IQR).

  • CK-MB, creatine kinase isoenzyme MB; PCI, percutaneous coronary intervention.